A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
This accidental discovery, made by medical biochemist Henry Pownall, Ph.D., and his team at the Houston Methodist Research Institute, reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in an article titled “ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate,” appearing online Oct. 26 and in print Nov. 21 in the American Heart Association’s Arteriosclerosis, Thrombosis, and Vascular Biology journal.
VIDEO: Dr. Pownall explains the research https://vimeo.com/239663429
Pownall, who is the corresponding author, said the initial purpose of their study was to prove the current model of cholesterol transport through the body was correct. It turns out, however, that the model was not quite right.
“The model people have been using for 40 years presumed that cholesterol was transported from the arteries with other lipids and proteins and entered a particle that stayed in the blood for several days before being cleared by the liver for disposal,” Pownall said. “What we discovered in the process was something different. We discovered the cholesterol skips all these steps and goes directly from this early particle to the liver in two minutes. This is a thousand times faster than what was formerly suspected.”
While most studies look at HDL cholesterol in its mature form found in blood, Pownall and his colleagues studied cholesterol in nascent HDL, an early form of HDL produced by cells. Cholesterol in the nascent HDL goes directly to the liver, largely skipping conversion to the mature form of HDL
Pownall stresses that it’s not that current practices of treating “bad” LDL cholesterol are incorrect, but instead that physicians and researchers need to better understand how the “good” HDL cholesterol contributes to cardiovascular disease and how to raise it in a way that protects the heart, because some patients with very high HDL numbers, which were always thought to be beneficial, are actually at risk.
“LDL cholesterol, the so-called ‘bad cholesterol’ is well controlled with the current statin therapies. The track record for these cholesterol-lowering drugs is indisputable, and they will continue to work,” Pownall said. “HDL, or the ‘good cholesterol,’ however, is a much trickier system. Not everything that raises it protects the heart and not everything that lowers it is bad for you. We will need to redesign new drugs to lower plasma cholesterol in a way that takes into account this new mechanism. We will look for interventions – maybe dietary, maybe pharmacological – that raise HDL cholesterol in a way that helps protect the arteries and prevent cardiovascular disease.”
Researchers collaborating with Pownall on this paper were Bingqing Xu, Baiba K. Gillard, Antonio M. Gotto Jr., and Corina Rosales, and the work was supported by a High-density Lipoprotein (HDL) Biogenesis and Speciation grant from the National Institutes of Health’s National Lung, Heart and Blood Institute (R01HL129767), Deutsche Forschungsgemeinschaft (Exc114-2) and Fondren Foundation.
For more information: ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate. Arteriosclerosis, Thrombosis, and Vascular Biology DOI: https://doi.org/10.1161/ATVBAHA.117.310290 (Oct. 26, 2017) B. Xu, B.K. Gillard, A.M. Gotto Jr., C. Rosales, H.J. Pownall.
Texas A&M University Health Science CenterTAMUhealthsciences
"We're expected to try to treat the patients' pain, but the only thing that is going to make someone seeking opioids happy is to feed their addiction. I have to...
Welcome home: After one year, local Veterans Court in Florida honors first graduate https://t.co/guLtso1fVa via @staugrecord
Today’s #VeteranOfTheDay is @usairforce Veteran Gary Peterson https://t.co/nvYwE7P7sM #AirForce
U.S. Department of Veterans AffairsVeteransAffairs
Today’s #VeteranOfTheDay is U.S. Air Force Veteran Gary Peterson. Gary served from 1990 to 2013 during the Gulf War and Iraq War. Gary was born in Roswell, New...
.@SecShulkin: “I think we’re making progress, but we have a lot more work to do.” https://t.co/8UlvXGpvN6 via @foxnews
MD Anderson Cancer Center@MDAndersonNews
#Ovariancancer survivor: “Life is 10% of what happens to us and 90% how we react to it.” https://t.co/QGvDS8gcJH… https://t.co/21hXNOu7oc
New hormone, asprosin, able to cross the blood-brain barrier and stimulate the brain’s hunger center. https://t.co/XwP5un8ElF #research
Baylor College of MedicineBaylorCollegeOfMedicine
The Cancer Research Institute brings Immunotherapy Patient Summit to the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. #cancer
MD Anderson Cancer Center@MDAndersonNews
#Breastcancer survivor explains how advance care planning helped her prepare for multiple scenarios… https://t.co/Mufvcn1btA
@NrsHolly We appreciate the RT ^SF
@JaimeESanchezMD Thanks for sharing ^SF
@CriscellaTX We appreciate the RT ^SF
MD Anderson Cancer CenterMDAnderson
“It takes a lot of strength and courage to get to where you are today, so let what you have gone through be your strength.” #endcancer
University of Houston@UHouston
RT @UHCougarMBK: RT this W! • FINAL Coogs defeat highest ranked opponent since Jan 6, 1996… @iRob_G leads all with 24 pts… @CoreyTheGreat_…